Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128M Sell
355,496
-165,802
-32% -$44.1M 0.03% 509
2026
Q1
$79.2M Buy
521,298
+84,499
+19% +$10.3M 0.02% 650
2025
Q4
$47.8M Buy
436,799
+230,429
+112% +$33.5M 0.01% 904
2025
Q3
$29.2M Sell
206,370
-2,187
-1% -$319K 0.01% 1173
2025
Q2
$33.7M Buy
208,557
+19,095
+10% +$2.37M 0.01% 1068
2025
Q1
$20.2M Buy
189,462
+6,736
+4% +$939K 0.01% 1305
2024
Q4
$22.5M Buy
182,726
+2,626
+1% +$370K 0.01% 1257
2024
Q3
$25.8M Buy
180,100
+7,623
+4% +$1.08M 0.01% 1190
2024
Q2
$28.2M Buy
172,477
+53,782
+45% +$6.69M 0.01% 1070
2024
Q1
$14.8M Sell
118,695
-273,145
-70% -$28.9M ﹤0.01% 1494
2023
Q4
$29.4M Buy
391,840
+189,291
+93% +$11.1M 0.01% 1051
2023
Q3
$10.8M Buy
+202,549
New +$11.2M ﹤0.01% 1633

Other funds holding ARM

Ameriprise's ARM Position: Q2 2026 in Review

Ameriprise reduced its Arm (ARM) stake by 32% in Q2 2026, selling an estimated $44.1M and leaving 355,496 shares worth $128M. The position accounts for 0.03% of the portfolio, ranked #509.

Ameriprise first reported a position in ARM in Q3 2023 and has held it in 12 quarters since. 957 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • Ameriprise held 355,496 shares of Arm worth $128M as of Q2 2026.
  • Ameriprise sold 165,802 Arm shares in Q2 2026, an estimated $44.1M.
  • Arm made up 0.03% of Ameriprise's portfolio in Q2 2026, its #509 holding.
  • Ameriprise first reported a position in Arm in Q3 2023 and has held it in 12 quarters since.
  • 957 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.